1 Scope and purpose
1.1 Definition
Clinical research is the systematic study of human health and disease in people, using organized methods to answer medical questions. It examines how conditions develop, how treatments perform, how preventive measures work, and how diagnostic tools influence care. Unlike routine clinical care, it follows a predefined research plan and produces evidence that can be analyzed, compared, and shared.
1.2 Goals of clinical research
The main goals of clinical research are to improve knowledge, support safer and more effective care, and measure outcomes that matter to patients. It may seek to determine whether an intervention works, identify side effects, compare alternatives, or describe patterns of disease in specific populations. In addition, it helps shape clinical guidelines, informs public health practice, and supports decision-making by clinicians, patients, and policymakers.
1.3 Distinction from basic and translational research
Basic research focuses on fundamental biological mechanisms, often in laboratory models or cells, while translational research aims to move discoveries from the lab toward practical applications. Clinical research is centered on human participants and the direct study of health-related questions in people. Although these areas overlap, clinical research is distinguished by its emphasis on patient-centered evidence, real-world outcomes, and the evaluation of interventions in human settings.
2 History
2.1 Early developments
Early clinical inquiry grew from observation, experience, and comparison of treatment approaches. Physicians gradually began to record outcomes more systematically, noting patterns in symptoms, recovery, and mortality. Over time, these efforts evolved into more structured studies that used comparison groups and clearer methods of assessment.
2.2 Modern clinical trial era
The modern era of clinical trials developed as medicine increasingly adopted controlled experimentation and statistical methods. Researchers began to use random allocation, standardized procedures, and predefined endpoints to reduce bias and improve reliability. This period established the framework for contemporary drug development, device evaluation, and therapeutic testing.
2.3 Ethical reforms and regulatory milestones
As human studies expanded, concerns about consent, safety, and fairness led to stronger ethical standards and legal oversight. Major reforms introduced formal review processes, protections for participants, and rules for trial conduct and reporting. These milestones helped define the responsibilities of investigators and institutions and made participant welfare a central requirement of research.
3 Study types
3.1 Interventional studies
Interventional studies assign participants to a specific treatment, procedure, behavioral program, or preventive strategy. Their purpose is to assess the effect of an action under planned conditions. Because the researcher introduces the intervention, these studies are especially useful for testing causality.
3.1.1 Clinical trials
Clinical trials are prospective studies that evaluate medical interventions in human participants. They may test new drugs, devices, procedures, or care strategies across early and later phases of development. Trials can assess safety, dosage, efficacy, and longer-term outcomes.
3.1.2 Randomized controlled trials
Randomized controlled trials assign participants to different groups by chance, often comparing an intervention with placebo, standard care, or another active treatment. Randomization helps balance known and unknown factors between groups, which strengthens causal interpretation. These trials are widely regarded as a high standard for evaluating effectiveness.
3.1.3 Crossover studies
In crossover studies, participants receive more than one intervention in a sequence, often separated by a washout period. Each participant may serve as their own control, which can increase efficiency and reduce variability. This design is most suitable when the condition is stable and the intervention has temporary effects.
3.2 Observational studies
Observational studies examine outcomes without assigning a treatment. Researchers observe what happens in natural settings and look for associations among exposures, diseases, and patient characteristics. These studies are useful when interventions cannot be ethically or practically assigned.
3.2.1 Cohort studies
Cohort studies follow groups of people over time to compare outcomes after different exposures or behaviors. They may be prospective or retrospective and are often used to estimate incidence and risk. This design helps identify possible links between factors and later health events.
3.2.2 Case-control studies
Case-control studies begin with individuals who have a particular outcome and compare them with similar individuals who do not. Researchers then look backward to assess prior exposures or characteristics. This approach is efficient for uncommon diseases and outcomes that take a long time to develop.
3.2.3 Cross-sectional studies
Cross-sectional studies measure exposures and outcomes at a single point in time. They are often used to estimate prevalence or to describe patterns within a population. Because they provide a snapshot rather than a sequence of events, they are limited in determining cause and effect.
3.3 Diagnostic and screening studies
Diagnostic studies evaluate how well a test identifies a condition in people who may already have symptoms. Screening studies examine the ability of a test or program to detect disease earlier in asymptomatic individuals. Both types assess accuracy, reliability, and clinical usefulness, often comparing results with a reference standard.
3.4 Outcomes and comparative effectiveness research
Outcomes research focuses on the results of care, including survival, quality of life, function, and patient experience. Comparative effectiveness research compares alternative interventions or care strategies to determine which works best in practice. It emphasizes meaningful outcomes and can inform choices among established treatments.
4 Clinical trial design
4.1 Research questions and hypotheses
A trial begins with a focused question and a testable hypothesis. Investigators define what they want to measure, in which population, and under what conditions. Clear questions improve the study design and help determine the appropriate methods for analysis.
4.2 Endpoints and outcome measures
Endpoints are the specific outcomes used to judge the effect of an intervention. They may be clinical events, laboratory values, symptoms, functional measures, or patient-reported outcomes. Careful selection of endpoints is essential because they shape interpretation and determine whether the study answers its main question.
4.3 Control groups and comparators
Control groups provide a basis for comparison and help distinguish the effect of an intervention from background change. Comparators may include placebo, usual care, another active treatment, or no treatment. The choice depends on ethics, feasibility, and the purpose of the study.
4.4 Randomization and blinding
Randomization reduces selection bias by assigning participants to groups unpredictably. Blinding limits expectation effects by preventing participants, clinicians, or assessors from knowing which treatment was given. Together, these methods strengthen the credibility of trial results when they are feasible.
4.5 Sample size and statistical power
Sample size planning estimates how many participants are needed to detect a meaningful effect with adequate confidence. Statistical power refers to the probability of finding a true difference if one exists. Studies that are too small may miss important effects, while excessively large studies may use more resources than necessary.
4.6 Adaptive trial designs
Adaptive designs allow preplanned modifications to some aspects of a trial based on interim data. Changes may include sample size adjustments, dropping ineffective arms, or refining eligibility criteria. These designs can improve efficiency, but they require careful statistical control and strong oversight.
5 Conduct of research
5.1 Protocol development
The protocol is the master document that describes the study objectives, methods, eligibility criteria, procedures, and analysis plan. It guides all stages of implementation and serves as a contract for scientific conduct. A well-written protocol promotes consistency across sites and supports ethical review.
5.2 Site selection and training
Research sites are chosen for their patient population, expertise, infrastructure, and ability to follow study procedures. Training ensures that investigators and staff understand the protocol, data collection methods, and safety requirements. Consistent preparation reduces errors and improves reliability across locations.
5.3 Participant recruitment and retention
Recruitment involves identifying eligible participants and informing them about the study. Retention focuses on keeping participants engaged long enough to complete the planned assessments. Clear communication, convenient scheduling, and respectful follow-up help reduce dropout and maintain study quality.
5.4 Data collection and management
Data collection may include clinical observations, questionnaires, laboratory results, imaging findings, and digital records. Data management systems organize, store, and protect these records while supporting accuracy and traceability. Good management practices help ensure that analyses are based on complete and dependable information.
5.5 Monitoring and quality assurance
Monitoring checks whether a study is being conducted according to the protocol and applicable standards. Quality assurance procedures detect discrepancies, incomplete records, and safety concerns. These measures protect participants and help preserve the validity of the findings.
5.6 Trial completion and closeout
At the end of a study, investigators verify that data are finalized, documents are archived, and required reports are prepared. Closeout may include site closure, reconciliation of materials, and resolution of outstanding queries. Proper completion supports transparency and allows results to move into analysis and reporting.
6 Ethics and participant protection
6.1 Informed consent
Informed consent is the process by which a person receives understandable information about a study and voluntarily agrees to participate. It includes the purpose, procedures, risks, benefits, and alternatives. Consent is both an ethical requirement and an ongoing process rather than a single signature.
6.2 Risk-benefit assessment
Ethical research requires that potential benefits justify foreseeable risks. Investigators and review bodies assess physical, psychological, social, and privacy-related harms before a study begins. The goal is to reduce unnecessary burden while preserving the scientific value of the work.
6.3 Vulnerable populations
Some groups may have limited ability to protect their own interests because of age, illness, dependence, or constrained decision-making. Additional safeguards are used when enrolling such participants, including clearer explanations, extra review, or permission from legally authorized representatives. The aim is to avoid exploitation and ensure fair treatment.
6.4 Privacy and confidentiality
Privacy refers to a person’s control over access to themselves and their information, while confidentiality concerns the handling of data after collection. Research teams are expected to limit access, secure records, and use identifiers appropriately. These protections help maintain trust and reduce the risk of harm from disclosure.
6.5 Institutional review boards and ethics committees
Institutional review boards and ethics committees review research plans to determine whether participant rights and welfare are adequately protected. They evaluate the consent process, risk minimization, and scientific merit. Their oversight is central to ethical conduct and helps ensure independent scrutiny before and during studies.
7 Regulation and oversight
7.1 National regulatory frameworks
Clinical research is governed by laws and regulations that vary by country but generally cover participant protection, study approval, and product evaluation. These frameworks define responsibilities for sponsors, investigators, and institutions. They also establish requirements for documentation, safety reporting, and inspection.
7.2 Good clinical practice
Good clinical practice is a set of internationally recognized principles for designing, conducting, recording, and reporting studies. It emphasizes scientific integrity, participant safety, and reliable documentation. Following these standards helps make results credible and acceptable to regulators and the scientific community.
7.3 Trial registration
Trial registration creates a public record of key study information before or near the start of enrollment. It improves transparency, reduces selective reporting, and helps others identify ongoing research. Registration also assists with accountability and comparison between planned and published outcomes.
7.4 Safety reporting and adverse event monitoring
Safety reporting tracks unwanted medical occurrences during a study. Serious or unexpected events may require prompt notification to sponsors, regulators, and ethics bodies. Ongoing monitoring helps identify patterns, evaluate causality, and protect participants from avoidable harm.
8 Statistics and data analysis
8.1 Descriptive statistics
Descriptive statistics summarize the characteristics of a sample, such as averages, proportions, and variation. They provide a clear picture of the population studied and the distribution of key variables. These summaries are usually the starting point for more advanced analysis.
8.2 Inferential methods
Inferential statistics allow researchers to draw conclusions beyond the observed sample. Methods such as hypothesis testing and confidence intervals help estimate effects and assess uncertainty. Proper interpretation depends on study design, assumptions, and the quality of the data.
8.3 Survival analysis
Survival analysis examines the time until an event occurs, such as death, relapse, or recovery. It is widely used when not all participants experience the event during the study period. This approach can accommodate differing follow-up times and censored observations.
8.4 Missing data handling
Missing data arise when measurements are not recorded or participants drop out before completion. Researchers use predefined approaches to reduce bias, such as careful follow-up, imputation, or model-based methods. The handling strategy can substantially affect study conclusions.
8.5 Subgroup and sensitivity analyses
Subgroup analyses explore whether effects differ across categories such as age, sex, or disease severity. Sensitivity analyses test whether results remain stable under alternative assumptions or methods. Both are useful for assessing robustness, though they must be interpreted cautiously to avoid overstatement.
9 Translational and applied contexts
9.1 Biomarker studies
Biomarker studies assess measurable indicators in blood, tissue, imaging, or other sources that may reflect disease activity or treatment response. They can support diagnosis, prognosis, or monitoring. A biomarker is most valuable when it is reliable, clinically meaningful, and linked to a relevant outcome.
9.2 Precision medicine
Precision medicine seeks to tailor prevention or treatment to characteristics of an individual or subgroup, such as genetic profile or molecular features. Clinical research evaluates whether this approach improves outcomes compared with broader strategies. It often combines laboratory findings with patient-level evidence.
9.3 Clinical epidemiology
Clinical epidemiology applies epidemiologic methods to questions arising in patient care. It studies disease patterns, risk factors, prognosis, and intervention effects in clinical populations. This approach connects population-based reasoning with bedside decision-making.
9.4 Real-world evidence
Real-world evidence comes from data generated outside tightly controlled trials, including routine care records, registries, and health system databases. It can show how interventions perform in everyday practice and among more diverse patients. Such evidence complements trial findings by extending understanding of effectiveness and use patterns.
10 Reporting and dissemination
10.1 Study reports and manuscripts
Study reports and manuscripts present the methods, results, and interpretation of research findings. Clear writing helps readers judge quality, limitations, and relevance. Accurate reporting is essential because published results often influence care, policy, and future research.
10.2 Reporting guidelines
Reporting guidelines provide structured recommendations for presenting different types of studies. They improve completeness, transparency, and comparability across publications. Common examples include standards for trials, observational studies, and systematic reviews.
10.3 Peer review and publication
Peer review is the evaluation of a manuscript by experts before publication. It helps identify weaknesses, clarify interpretation, and improve presentation. Publication then makes the findings available to the scientific community and broader public.
10.4 Data sharing and transparency
Data sharing allows other researchers to inspect, verify, and sometimes reuse study data under appropriate safeguards. Transparency also includes sharing protocols, analysis plans, and disclosure of funding or conflicts of interest. These practices support reproducibility and public trust.
11 Careers and roles
11.1 Investigators and subinvestigators
Investigators lead studies and are responsible for the scientific and ethical conduct of the research. Subinvestigators assist with clinical evaluation, participant oversight, and protocol implementation. Their work combines subject-matter knowledge with careful adherence to study procedures.
11.2 Clinical research coordinators
Clinical research coordinators manage many day-to-day activities of a study, including scheduling, documentation, and communication with participants. They often serve as a central link between the research team and the site. Their organizational skills are crucial for smooth study operations.
11.3 Data managers and statisticians
Data managers oversee data systems, cleaning, and quality checks, while statisticians plan analyses and interpret results. Both roles are important for ensuring that conclusions are based on accurate and appropriately analyzed information. They contribute from study design through final reporting.
11.4 Research nurses and study staff
Research nurses and other study staff assist with participant care, specimen handling, assessments, and follow-up. They help maintain protocol compliance and support participant understanding. Their work often combines clinical expertise with research-specific responsibilities.
12 Challenges and future directions
12.1 Recruitment barriers
Recruitment can be slowed by strict eligibility criteria, limited awareness, time constraints, and concerns about study burden. Under-enrollment may delay completion or reduce statistical power. Researchers increasingly use community outreach, better communication, and flexible procedures to improve participation.
12.2 Reproducibility and bias
Clinical research can be affected by selection bias, measurement error, selective reporting, and other sources of distortion. Reproducibility improves when methods are transparent, data handling is rigorous, and protocols are followed consistently. Ongoing attention to design and reporting is needed to strengthen confidence in findings.
12.3 Decentralized and digital trials
Decentralized trials use remote methods such as telehealth visits, home sampling, and electronic data capture to reduce the need for frequent site visits. Digital tools may broaden access and make participation more convenient. At the same time, they require strong attention to data security, usability, and verification of collected information.
12.4 Artificial intelligence in clinical research
Artificial intelligence is increasingly used to support screening, data analysis, imaging interpretation, and identification of patterns in large datasets. It may improve efficiency and reveal relationships that are difficult to detect manually. Its use also raises questions about validation, transparency, and the need for careful human oversight.